Tvardi Therapeutics, Inc. (BX:TVRD) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Cynthia Smith Other companies: Agios Pharmaceuticals, Inc. (Independent Director · Since at least Aug 11, 2022); Protara Therapeutics, Inc. (Director · Since at least Jan 29, 2021); Spero Therapeutics, Inc. (Director · Since at least Mar 19, 2019); Akebia Therapeutics, Inc. (Senior Vice President, Market Access and Commercial Development · Since at least Aug 28, 2018); Dicerna Pharmaceuticals Inc (Director · Aug 13, 2018 – Dec 28, 2021 · Past); Alpine Immune Sciences Inc (Director · Nov 1, 2016 – Nov 1, 2016 · Past); ZS Pharma Inc (Chief Commercial Officer · Jun 17, 2014 – Dec 17, 2015 · Past) | Board Member · Since at least Apr 15, 2025 |
| Edward Hurwitz Other companies: Dyne Therapeutics, Inc. (Director · Since at least Jul 31, 2020); MacroGenics, Inc. (Director · Since at least Oct 9, 2013); Turmeric Acquisition Corp (Chief Financial Officer · Oct 15, 2020 – Oct 15, 2020 · Past); Sunesis Pharmaceuticals Inc (Director · Apr 3, 2009 – Jun 28, 2013 · Past) | Director · Jan 30, 2014 – Feb 5, 2014 · Past |
| Helen M. Boudreau Other companies: Rallybio Corporation (Board Member · Since at least Jul 29, 2021); Shattuck Labs, Inc. (Director · Since at least Oct 8, 2020); Kineta Inc. (Chief Financial Officer · Feb 10, 2016 – Mar 1, 2018 · Past) | Director · Aug 2, 2023 – Jun 4, 2024 · Past |
| Mani Mohindru Other companies: Cardiff Oncology, Inc. (President & Chief Executive Officer · Since at least Jun 10, 2021); CytomX Therapeutics, Inc. (Director · Since at least Dec 16, 2020); Curis, Inc. (Chief Strategy Officer · Jan 19, 2016 – Feb 14, 2017 · Past) | CFO & Chief Strategy Officer · Aug 15, 2017 – Dec 2, 2019 · Past |
| Martin Vogelbaum Other companies: Rocket Pharmaceuticals, Inc. (Director · Feb 17, 2015 – Jun 24, 2015 · Past); NephroGenex Inc (Director · Feb 10, 2014 – May 15, 2014 · Past); MiddleBrook Pharmaceuticals Inc (Director · Apr 20, 2007 – Jun 23, 2009 · Past) | Director · Jan 30, 2014 – Jun 4, 2024 · Past |
| Michael Wyzga Other companies: Mereo BioPharma Group plc (Director · Since at least Feb 26, 2026); X4 Pharmaceuticals, Inc. (Director · Since at least Jun 9, 2025); Kineta Inc. (See Remarks · Aug 16, 2021 – Dec 2, 2022 · Past) | Board Member · Since at least Apr 15, 2025 |
| Ryan Maynard Other companies: Foghorn Therapeutics Inc. (Chief Financial Officer · Since at least Feb 23, 2026); Iovance Biotherapeutics, Inc. (Director · Since at least Feb 16, 2015); Rigel Pharmaceuticals, Inc. (EVP & CFO · May 27, 2010 – Nov 3, 2017 · Past) | CHIEF FINANCIAL OFFICER · Sep 12, 2022 – Feb 8, 2024 · Past |
| Lisa von Moltke Other companies: Zenas BioPharma, Inc. (Head of Research and Development and Chief Medical Officer · Since at least Mar 17, 2025); Seres Therapeutics, Inc. (See Remarks · Apr 6, 2020 – Feb 15, 2025 · Past) | Director · Nov 1, 2022 – Jun 4, 2024 · Past |
| Harrison M Bains Jr Other companies: BG Medicine Inc (Director · Jun 12, 2013 – Jun 3, 2014 · Past) | Director · Jul 16, 2014 – Jun 1, 2023 · Past |
| Jeffrey L Ives Other companies: Acumen Pharmaceuticals, Inc. (Director · Since at least Jun 30, 2021) | Director · Jul 16, 2014 – Jun 4, 2024 · Past |
| Joana Goncalves Other companies: Oruka Therapeutics, Inc. (Chief Medical Officer · Since at least Aug 29, 2024) | CHIEF MEDICAL OFFICER · Oct 22, 2018 – Apr 5, 2024 · Past |
| Shaheen Wirk Other companies: Corvex, Inc. (Director · Since at least Jan 2, 2025) | Director · Apr 15, 2025 – Apr 17, 2025 · Past |
| Thomas Charles Reilly Other companies: Amarin Corporation plc (EVP and CFO · Jun 30, 2022 – Jul 1, 2024 · Past) | Chief Financial Officer · Oct 1, 2020 – Mar 3, 2022 · Past |
| Avi Daniel Conn | Chief Financial Officer · Since at least Apr 15, 2025 |
| Christopher Posner | PRESIDENT AND CEO, Director · Nov 2, 2023 – Feb 28, 2025 · Past |
| Dan Conn | Chief Financial Officer · Since at least Nov 4, 2026 |
| David Tweardy | Co-Founder · Since at least Nov 4, 2026 |
| Dean Slagel | Director · Jun 15, 2016 – Jun 29, 2017 · Past |
| Derek T Chalmers | President & CEO, Director · Jan 6, 2016 – Sep 7, 2021 · Past |
| Frederique Ph D Menzaghi | CHIEF SCIENTIFIC OFF,SVP-R&D · Jan 30, 2014 – Feb 1, 2024 · Past |
| Imran Alibhai | Chief Executive Officer · Since at least Apr 15, 2025 |
| Jeffrey Leroy Larson | SVP, Research & Development · Apr 15, 2025 – Apr 17, 2025 · Past |
| John Kauh | Chief Medical Officer · Since at least Apr 15, 2025 |
| Josef Schoell | Chief Financial Officer · Jan 30, 2014 – Jul 26, 2017 · Past |
| Kari Anne Rowland | Vice President, Clinical Operations · Since at least Nov 5, 2026 |
| Michael T. Lewis | Co-Founder & Professor, Molecular and Cellular Biology and Radiology · Since at least Nov 4, 2026 |
| Richard Makara | VP, Head of Accting;Controller · Jun 15, 2022 – Jun 15, 2022 · Past |
| Ron DePinho | Co-Founder & Chairman of Scientific Advisory Board · Since at least Nov 4, 2026 |
| Scott Terrillion | SEC'Y; CHIEF COMPLIANCE & G.C. · May 1, 2017 – Feb 28, 2025 · Past |
| Sofia de Achaval | Vice President, Development · Since at least Nov 5, 2026 |
| Stephen O’Brien | VP, Finance and Corporate Controller · Since at least Apr 15, 2025 |
| Sujal Shah | Chairman of the Board · Since at least Apr 15, 2025 |
| Susan Shiff | Director · Since at least Jun 26, 2020 |
| Wallace Hall | Board Member · Since at least Nov 5, 2026 |
| Wallace L Hall Jr | Director · Since at least Apr 15, 2025 |
| Yixin Joseph Chen | Vice President, CMC · Since at least Apr 15, 2025 |